Drug Safety, Medical Device, And Laboratory Regulation
US Congress 117th Congress
Marijuana Data Collection Act [HB-3043]
[Cannabis ]
[Healthcare ]
[Science ]
[Public Health ]
To direct the Secretary of Health and Human Services to enter into a 10-year arrangement with the National Academy of Sciences to conduct and update biennially a study on the effects of State legalized marijuana programs, and for other purposes.
HB-3043: Marijuana Data Collection Act
Sponsored by: Rep. Don Young
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 11/09/2021
S.1508: A bill to provide for the use of emergency use authorization data and real world evidence gathered during an emergency to support premarket applications for drugs, biological products, and devices, and for other purposes.
Sponsored by: Sen. Roger Marshall
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
You have voted S.1508: A bill to provide for the use of emergency use authorization data and real world evidence gathered during an emergency to support premarket applications for drugs, biological products, and devices, and for other purposes..
Gabriella Miller Kids First Research Act 2.0 [S.1521]
[Healthcare ]
[Funding ]
[Grants ]
[Public Health ]
[Science ]
[Children and Youth ]
A bill to require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.
S.1521: Gabriella Miller Kids First Research Act 2.0
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
Marijuana Data Collection Act [S.1456]
[Cannabis ]
[Healthcare ]
[Science ]
[Public Health ]
A bill to direct the Secretary of Health and Human Services to enter into a 10-year arrangement with the National Academy of Sciences to conduct and update biennially a study on the effects of State legalized marijuana programs, and for other purposes.
S.1456: Marijuana Data Collection Act
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
Changing the Culture of the FDA Act [S.1436]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
A bill to direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.
S.1436: Changing the Culture of the FDA Act
Sponsored by: Sen. Joe Manchin
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/28/2021
FDA Accountability for Public Safety Act [S.1439]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Overdose Prevention ]
[Public Safety ]
A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.
S.1439: FDA Accountability for Public Safety Act
Sponsored by: Sen. Angus King
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/28/2021
Stop STALLING Act Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act [S.1425]
[Pharmaceuticals ]
[Healthcare ]
[Consumer Protection ]
[Public Health ]
A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
S.1425: Stop STALLING Act Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act
Sponsored by: Sen. Chuck Grassley
Committee On The Judiciary. Reported By Senator Durbin Without Amendment. Without Written Report. on 12/08/2021
S.1435: Affordable Prescriptions for Patients Act of 2021
Sponsored by: Sen. Chuck Grassley
Committee On The Judiciary. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. on 07/29/2021
Stop Stalling Access to Affordable Medications [HB-2883]
[Healthcare ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
HB-2883: Stop Stalling Access to Affordable Medications
Sponsored by: Rep. David Cicilline
Committee Consideration And Mark-up Session Held. on 09/29/2021
Prompt Approval of Safe Generic Drugs Act [HB-2831]
[Healthcare ]
[Pharmaceuticals ]
[Consumer Protection ]
To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes.
HB-2831: Prompt Approval of Safe Generic Drugs Act
Sponsored by: Rep. Nanette Barragan
Referred To The Subcommittee On Health. on 04/27/2021
Elijah E. Cummings Lower Drug Costs Now Act [HB-3]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.
HB-3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Oversight And Investigations. on 04/27/2021
Lower Costs, More Cures Act of 2021 [HB-19]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Public Health ]
To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes.
HB-19: Lower Costs, More Cures Act of 2021
Sponsored by: Rep. Steve Scalise
Referred To The Subcommittee On Antitrust, Commercial, And Administrative Law. on 10/19/2021